Description
Tesamorelin is a synthetic analog of human growth hormone-releasing hormone, or GHRH, developed with structural modifications that improve stability compared with naturally occurring GHRH. FDA substance records identify tesamorelin as a 44-amino-acid peptide and classify it as a growth hormone-releasing factor analog.
Tesamorelin peptide research commonly examines growth hormone signaling, pituitary response, IGF-1 regulation, metabolic pathways, and body-composition-related mechanisms under controlled laboratory conditions. It’s defined interaction with the growth hormone axis also makes it relevant to experimental studies involving endocrine signaling and metabolic regulation.
Features
- Composition: Synthetic 44-amino-acid GHRH analog
- Research Classification: Growth hormone-releasing factor analog
- Alternative Research Name: TH-9507
- CAS Number: 218949-48-5
- Format: Supplied as lyophilized powder
- Research Focus: Growth hormone signaling, endocrine pathways, metabolic regulation, and IGF-1 response
- Tesamorelin research applications include controlled investigation of GHRH-related signaling and downstream biological responses
- Recommended Storage: −20 °C
Disclaimer: Supplied strictly for laboratory research. Not intended for human or veterinary use, administration, consumption, diagnosis, treatment, or therapeutic purposes.
Reviews
There are no reviews yet.